<html xmlns="http://www.w3.org/1999/html">
<head>
	
	<meta charset="utf-8">
    <meta name="viewport" content="target-densitydpi=device-dpi, width=device-width, initial-scale=1.0, maximum-scale=1">
    <meta name="description" content="Metro UI CSS">
    <meta name="author" content="Sergey Pimenov">
    <meta name="keywords" content="windows 8, modern style, Metro UI, style, modern, css, framework">

    <link href="css/modern.css" rel="stylesheet">
    <link href="css/modern-responsive.css" rel="stylesheet">
    <link href="css/site.css" rel="stylesheet" type="text/css">
    <link href="js/google-code-prettify/prettify.css" rel="stylesheet" type="text/css">
	<link href='http://fonts.googleapis.com/css?family=Lato:900' rel='stylesheet' type='text/css'>
	<link href='http://fonts.googleapis.com/css?family=Arvo' rel='stylesheet' type='text/css'>
	
    <script type="text/javascript" src="js/assets/jquery-1.9.0.min.js"></script>
    <script type="text/javascript" src="js/assets/jquery.mousewheel.min.js"></script>
    <script type="text/javascript" src="js/assets/moment.js"></script>
    <script type="text/javascript" src="js/assets/moment_langs.js"></script>

    <script type="text/javascript" src="js/modern/dropdown.js"></script>
    <script type="text/javascript" src="js/modern/accordion.js"></script>
    <script type="text/javascript" src="js/modern/buttonset.js"></script>
    <script type="text/javascript" src="js/modern/carousel.js"></script>
    <script type="text/javascript" src="js/modern/input-control.js"></script>
    <script type="text/javascript" src="js/modern/pagecontrol.js"></script>
    <script type="text/javascript" src="js/modern/rating.js"></script>
    <script type="text/javascript" src="js/modern/slider.js"></script>
    <script type="text/javascript" src="js/modern/tile-slider.js"></script>
    <script type="text/javascript" src="js/modern/tile-drag.js"></script>
    <script type="text/javascript" src="js/modern/calendar.js"></script>
	
	
	
	<style>
	i 
	{
	float:left!important;margin-right:10px
	}
	body 
	{
	background-image:url("http://i264.photobucket.com/albums/ii179/chelstephenson/aquapoppydesigns/misty_2ss.jpg"); 
	background-position: center; 
	background-repeat: no-repeat; 
	background-attachment: fixed; 
	}	
	</style>
	<style>
	.triangle-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:33px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle-isosceles.left:after {
	content:"";
	position:absolute;
	top:50px; /* controls vertical position */
	left:-210px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 210px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle1-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle1-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:80px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle1-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle1-isosceles.left:after {
	content:"";
	position:absolute;
	top:55px; /* controls vertical position */
	left:-100px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 100px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle2-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle2-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:25px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle2-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle2-isosceles.left:after {
	content:"";
	position:absolute;
	top:25px; /* controls vertical position */
	left:-280px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 280px 5px 0;
	border-color:transparent#C8B593;
    }	    
	</style>
	
	<style>
	.triangle3-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle3-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:5px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle3-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle3-isosceles.left:after {
	content:"";
	position:absolute;
	top:10px; /* controls vertical position */
	left:-330px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 330px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle4-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle4-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:37px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle4-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle4-isosceles.left:after {
	content:"";
	position:absolute;
	top:23px; /* controls vertical position */
	left:-220px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 220px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle5-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle5-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:298px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle5-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle5-isosceles.left:after {
	content:"";
	position:absolute;
	top:18px; /* controls vertical position */
	left:-100px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 100px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle6-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle6-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:190px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle6-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle6-isosceles.left:after {
	content:"";
	position:absolute;
	top:25px; /* controls vertical position */
	left:-480px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 480px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle7-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle7-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:363px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle7-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle7-isosceles.left:after {
	content:"";
	position:absolute;
	top:10px; /* controls vertical position */
	left:-250px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 250px 3px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle8-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle8-isosceles.left {
	margin-left:550px;
	background:#C8B593;
	margin-top:155px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle8-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle8-isosceles.left:after {
	content:"";
	position:absolute;
	top:20px; /* controls vertical position */
	left:-480px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 480px 5px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
	<style>
	.triangle9-isosceles {
	position:relative;
	padding:5px;
	margin:1em 0 3em;
	color:#000;
	background:#f3961c; /* default background for browsers without gradient support */
	/* css3 */
	background:-webkit-gradient(linear, 0 0, 0 100%, from(#f9d835), to(#f3961c));
	background:-moz-linear-gradient(#f9d835, #f3961c);
	background:-o-linear-gradient(#f9d835, #f3961c);
	background:linear-gradient(#f9d835, #f3961c);
	-webkit-border-radius:10px;
	-moz-border-radius:10px;
	border-radius: 10px;}
	
    .triangle9-isosceles.left {
	margin-left:500px;
	background:#C8B593;
	margin-top:265px;
	font-family: 'Arvo', serif;
	font-weight: 400;
	font-size: 10pt;
	letter-spacing: 0.02em;
	line-height: 12pt;
	font-smooth: always;
    }
	.triangle9-isosceles:after {
	content:"";
	position:absolute;
	bottom:-15px; /* value = - border-top-width - border-bottom-width */
	left: -83px; /* controls horizontal position */
	border-width:14px 83px 14px 0; /* vary these values to change the angle of the vertex */
	border-style:solid;
	border-color:#f3961c transparent;
    }
	.triangle9-isosceles.left:after {
	content:"";
	position:absolute;
	top:70px; /* controls vertical position */
	left:-150px; /* value = - border-left-width - border-right-width */
	bottom:auto;
	border-width:5px 150px 7px 0;
	border-color:transparent #C8B593;
    }	    
	</style>
	
    <title>Clinical Trials</title>
</head>

<body class="metrouicss" onload="prettyPrint()">	
    <div class="page-region">
        <div class="page-region-content">
		    <div class="grid">
                <div class="row">	
					<div class="span6 bg-color-purple">												
						<h2 class="fg-color-white">&nbsp;<i class="icon-info-2" style="font-size: 40px; color: white;"></i>Titles and Background Info</h2>							
						<div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 300px;">
								<strong>Brief Title :</strong> A study of Induction and Maintenance Treatment of Advanced <u>Non-squamous</u> Non-Small Cell Lung Cancer.
								<p><strong>Brief  Summary :</strong>This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. 
										Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be 
										randomized 2:1 to receive either maintenance <u>pemetrexed or placebo.</u></p>
								<p><strong>Disease Condition :</strong>Non-Small Cell Lung Cancer.</p>
								<p><strong>Study-Type :</strong><u>Interventional.</u></p>
								
								<p><strong>Study-Phase :</strong><u>Phase-3</u>.</p>
								
							</div>
						</div>							
					</div>								
				</div>
				
				<div class="content">
					<p class="triangle-isosceles left">Non-small(Squamous) cell lung cancer is a disease in which malignant 
						(cancer) cells form in the tissues of the lung. They are relatively insensitive to chemotherapy, 
						compared to small cell lung cancer.There are several types of non-small cell lung cancer.</p>					
				</div>
				<div class="content">
					<p class="triangle1-isosceles left">Pemetrexed is a chemotherapy drug manufactured 
							and marketed by Eli Lilly and Company.<br>Placebos in medical research, are 
							given as control treatments and depend on the use of measured deception</p> 
				</div>
				<div class="content">
					<p class="triangle2-isosceles left">Interventional is an attempt to compel a subject to "get help" for an addiction or other problem.</p> 
				</div>
				<div class="content">
					<p class="triangle3-isosceles left">Phase 0: These trials are the first-in-human trials.<br>
						Phase 1: Screening for safety<br>
						Phase 2: Establishing the efficacy of the drug, usually against a placebo<br>
						Phase 3: Final confirmation of safety and efficacy<br>
						Phase 4: Sentry studies during sales</p>	
				</div>	
				
			</div>
			<div class="grid">
			    <div class="row">
					<div class="span6 bg-color-green">
						<h2 class="fg-color-white">&nbsp;<i class="icon-warning"></i>Status</h2>						
							<div class="image-container bg-color-lighten " style="width: 100%">
								<div style="height: 300px;">
								<p><strong>Overall Recruitment Status :</strong> Active, not recruiting.</p>

								<p><strong>Timeline of Study<br> (Recruitment -> Anticipated Completion) :</strong>
									<ul>
									<i class="icon-star-2"></i>Enrollment : 939<br>
									<i class="icon-star-2"></i>ESTIMATED COMPLETION DATE : September 2013<br>
									<i class="icon-star-2"></i>PRIMARY COMPLETION DATE : June 2010 (final data collection date for primary outcome measure)<br>							
									<i class="icon-star-2"></i>SPONSOR : Eli Lilly and Company<br>							
									<i class="icon-star-2"></i>CENTRAL CONTRACT : ClinicalTrials.gov
									</ul>
								</div>
							</div>	                       
					</div>
				</div>	
			</div>		
			<div class="grid">
				<div class="row">
					<div class="span6 bg-color-blue">                        
                        <h2 class="fg-color-white">&nbsp;<i class="icon-user" style="font-size: 30px; color: white;"></i>Patient Consideration</h2>
						<div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 267px;">
								<p><strong>Risk/Benefit of Study Participation :</strong> Not mentioned.</p>
								<p><strong>Study Logistics :</strong></p> 								
									<ul >									  									 									  
										<i class="icon-star-2"></i>ALLOCATION: Randomized<br>
										<i class="icon-star-2"></i>ENDPOINT CLASSIFICATION: Safety/Efficacy Study<br>
										<i class="icon-star-2"></i>INTERVENTION MODEL: Parallel Assignment<br>
										<i class="icon-star-2"></i>MASKING: Double Blind (Subject,Caregiver,Investigator,Outcomes Assessor) <br>
										<i class="icon-star-2"></i>PRIMARY PURPOSE: Treatment<br>																	  	
									</ul>
								<p><strong>Post Study Plans :</strong></p>
							</div>                           
                        </div>
                    </div>
				</div>
			</div>	
			<div class="grid">
			    <div class="row">
					<div class="span7 bg-color-greenLight">
						<h2 class="fg-color-white">&nbsp;<i class="icon-location" style="font-size: 30px; color: white;"></i>Site Locations</h2>
						<div class="image-container bg-color-lighten" style="width: 100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Australia, South Australia</p>
								<p><strong>Facility Address :</strong> Adelaide, South Australia,Australia, 5000</p>
								<p><strong>Facility Contact :</strong> 1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Australia, Victoria</p>
								<p><strong>Facility Address :</strong> Frankston, Victoria,Australia, 3199</p>
								<p><strong>Facility Contact :</strong> 1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Australia, Victoria</p>
								<p><strong>Facility Address :</strong> Wendouree, Victoria,Australia, 3355 <br></p>                                       
								<p><strong>Facility Contact :</strong> 1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Aalst, Belgium, 9300<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Brussels, Belgium, 1200<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Genk, Belgium, 3600<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Gilly, Belgium, 6060<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Liege, Belgium, 4000<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Belgium</p>
								<p><strong>Facility Address :</strong> Sint Niklaas, Belgium, 9100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Finland</p>
								<p><strong>Facility Address :</strong> Espoo, Finland, 02740<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>		
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Finland</p>
								<p><strong>Facility Address :</strong> Helsinki, Finland, 00290<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Finland</p>
								<p><strong>Facility Address :</strong> Tampere, Finland, 33520<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Finland</p>
								<p><strong>Facility Address :</strong> Turku, Finland, 20520<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong> Avignon, France, 84082<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Dijon, France, 21034<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Le Mans Cedex 1, France, 72037<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Montpellier, France, F-34295<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Nantes, France, 44202<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Paris, France, 75015<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Vandoeuvre Les Nancy, France, 54511<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> France</p>
								<p><strong>Facility Address :</strong>Vandoeuvre Les Nancy, France, 54511<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Frankfurt, Germany, 60596<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Gerlingen, Germany, 70839<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Gro√ühansdorf, Germany, D-22927<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Hamburg, Germany, D-20251<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Heidelberg, Germany, 69126<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Germany</p>
								<p><strong>Facility Address :</strong>Ulm, Germany, 89075<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Greece</p>
								<p><strong>Facility Address :</strong>Athens, Greece<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Greece</p>
								<p><strong>Facility Address :</strong>Chania, Greece, 73300<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Greece</p>
								<p><strong>Facility Address :</strong>Neo Faliro, Greece, 18547<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Greece</p>
								<p><strong>Facility Address :</strong>Patras, Greece, 26500<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> India</p>
								<p><strong>Facility Address :</strong>Bangalore, India, 560 078<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> India</p>
								<p><strong>Facility Address :</strong>Bhopal, India, 462001<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> India</p>
								<p><strong>Facility Address :</strong>Madurai, India, 625020<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> India</p>
								<p><strong>Facility Address :</strong>Mumbai, India, 400 012<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> India</p>
								<p><strong>Facility Address :</strong>Patna, India, 800 014<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Avellino, Italy, 83100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Aviano, Italy, 33081<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Genova, Italy, 16132<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Lido Di Camaiore, Italy, 55043<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Monza, Italy, 20052<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Pisa, Italy, 56100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Reggio Emilia, Italy, 42100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Rome, Italy, 00149<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Italy</p>
								<p><strong>Facility Address :</strong>Udine, Italy, 33100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Netherlands</p>
								<p><strong>Facility Address :</strong>Ede, Netherlands, 6716 RP<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Netherlands</p>
								<p><strong>Facility Address :</strong>Groningen, Netherlands, 9728 NT<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Netherlands</p>
								<p><strong>Facility Address :</strong>Harderwijk, Netherlands, 3844 DG<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Netherlands</p>
								<p><strong>Facility Address :</strong>Heerlen, Netherlands, 6419 PC<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Poland</p>
								<p><strong>Facility Address :</strong>Poznan, Poland, 60-569<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Poland</p>
								<p><strong>Facility Address :</strong>Warsaw, Poland, 02-781<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Portugal</p>
								<p><strong>Facility Address :</strong>Coimbra, Portugal, 3040-853<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Portugal</p>
								<p><strong>Facility Address :</strong>Lisbon, Portugal, 1099-035<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Portugal</p>
								<p><strong>Facility Address :</strong>Vila Franca De Xira, Portugal, 4434-502<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Romania</p>
								<p><strong>Facility Address :</strong>Bucharest, Romania, 022328<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Romania</p>
								<p><strong>Facility Address :</strong>Cluj-Napoca, Romania, 3400<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Romania</p>
								<p><strong>Facility Address :</strong>Oradea, Romania, 3700<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Spain</p>
								<p><strong>Facility Address :</strong>Manresa, Spain, 308243<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Spain</p>
								<p><strong>Facility Address :</strong>Sabadell, Spain, 08208<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Spain</p>
								<p><strong>Facility Address :</strong>Sevilla, Spain, 41013<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Spain</p>
								<p><strong>Facility Address :</strong>Valencia, Spain, 46017<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Spain</p>
								<p><strong>Facility Address :</strong>Zaragoza, Spain, 50009<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Turkey</p>
								<p><strong>Facility Address :</strong>Bornova, Turkey, 35100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Turkey</p>
								<p><strong>Facility Address :</strong>Sihhiye, Turkey, 06100<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> Turkey</p>
								<p><strong>Facility Address :</strong>Zeytinburnu, Turkey, 034760<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> United Kingdom</p>
								<p><strong>Facility Address :</strong>Aberdeen, Scotland, United Kingdom, AB25 2ZN<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> United Kingdom</p>
								<p><strong>Facility Address :</strong>Guildford, Surrey, United Kingdom, GU2 7XX<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>	
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 300px;">
								<p><strong>Facility Name :</strong> United Kingdom</p>
								<p><strong>Facility Address :</strong>Birmingham, West Midlands, United Kingdom, B15 2TH<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
						<div class="image-container bg-color-lighten" style="width:100%">
							<div style="height: 290px;">
								<p><strong>Facility Name :</strong> United Kingdom</p>
								<p><strong>Facility Address :</strong>Newcastle, United Kingdom, NE7 7DN<br></p>                                       
								<p><strong>Facility Contact :</strong>1-877-CTLILLY<br>(1-877-285-4559, 1-317-615-4559)</p>
								<p><strong>Site Recruitment Status:</strong>
								<p><strong>Investigator(s) :</strong> <br>Study Director :<br> Call 1-877-CTLILLY (1-877-285-4559) or <br> 
										   1-317-615-4559 <br> Mon - Fri 9 AM - 5 PM<br> Eastern time (UTC/GMT - 5 hours, EST)<br>
										   Eli Lilly and Company.</p>
							</div>						
						</div>
					</div>																
				</div>
			</div>												         			
			<div class="grid">
				<div class="row">
					<div class="span6 bg-color-orangeDark">						
						<h2 class="fg-color-white">&nbsp;<i class="icon-accessibility" style="font-size: 30px; color: white;"></i>Eligibility : Inclusion Criteria</h2>
						 <div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 730px;">							
								<ul>
									<i class="icon-checkmark"></i>You must sign an <u>informed consent</u> document for clinical research.<br>
									<i class="icon-checkmark"></i>You must have Stage IIIB or IV nonsquamous Non-Small Cell Lung Cancer.<br>
									<i class="icon-checkmark"></i>You must at least be able to be physically mobile, take care of yourself, and must be up and about and able to perform light activities such as light housework or office work.<br>
									<i class="icon-checkmark"></i>You are allowed to have had prior radiation therapy as long as it was not to more than 25% of the bone marrow and did not include the whole pelvis. Thoracic radiation must be completed more than 30 days before the study. You must be recovered from the toxic effects (except hair loss).<br>
									<i class="icon-checkmark"></i>You must have at least 1 measurable tumor <u>lesion</u> according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines or disease that can be evaluated by computed tomography (CT) Scan.<br>
									<i class="icon-checkmark"></i>Your test results assessing the function of your blood forming tissue, kidneys, and liver must be satisfactory.<br>
									<i class="icon-checkmark"></i>You must be 18 years of age or older.<br>
									<i class="icon-checkmark"></i>Women must be sterile, postmenopausal or on contraception and men must be on contraception or <u>sterile.</u>
								</ul>
								<p><strong>Gender :</strong> Both</p>

								<p><strong>Age Limits:</strong> 18 years and Older.</p>

								<p><strong>Ethnicity :</strong> Any</p>

								<p><strong>Genetic Mutation Type :</strong></p>

								<p><strong>Biomarker(s) :</strong></p>
							</div>	
						</div>
					</div>
				</div>
				<div class="content">
					<p class="triangle4-isosceles left">Informed consent is a legally defined process of a person being told 
					about key facts involved in a clinical trial before deciding whether or not to participate</p>
				</div>
				<div class="content">
					<p class="triangle5-isosceles left">A lesion is any abnormality in the tissue of an organism , usually caused by disease or trauma.</p>
				</div>
				<div class="content">
					<p class="triangle6-isosceles left">Sterile is a physical condition which refers to the inability to give birth.
						The condition of a person being unable to bear children, especially through natural means</p>
				</div>
			</div>	
			<div class="grid">
				<div class="row">
					<div class="span6 bg-color-orangeDark">
						<h2 class="fg-color-white">&nbsp;<i class="icon-accessibility" style="font-size: 30px; color: white;"></i>Eligibility : Exclusion Criteria</h2>
						<div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 890px;">												
								<ul>
									<i class="icon-cancel-2"></i>You cannot have squamous cell and/or mixed small cell, non-small cell lung cancer<br>
									<i class="icon-cancel-2"></i>You cannot have received other investigational drugs within the last 30 days of entering the trial.<br>
									<i class="icon-cancel-2"></i>You cannot have previously completed or withdrawn from this study or any other study investigating pemetrexed.<br>
									<i class="icon-cancel-2"></i>You cannot have other serious on-going illnesses including active infections.<br>
									<i class="icon-cancel-2"></i>You cannot have a serious cardiac condition, such as a heart attack, angina, or heart disease within 6 months of entering the trial.<br>
									<i class="icon-cancel-2"></i>You cannot have had another form of cancer other than superficial <u>basal cell</u> and superficial squamous (skin) cell cancer, or carcinoma in situ of the cervix within the last 5 years. Patients with a history of low-grade (Gleason score less than or equal to 6) localized prostate cancer will be eligible even if diagnosed less than 5 years ago.<br>
									<i class="icon-cancel-2"></i>You cannot have known central nervous system (CNS) metastases, other than treated, stable brain <u>metastasis</u><br>
									<i class="icon-cancel-2"></i>You cannot be receiving nor have received any prior systemic anticancer therapy for lung cancer (including chemotherapy given after surgery in early-stage treatment).<br>
									<i class="icon-cancel-2"></i>You cannot have clinically significant third-space fluid collections (e.g. ascites or pleural effusions that cannot be controlled by drainage or other procedures).<br>
									<i class="icon-cancel-2"></i>You cannot have received a recent (within 30 days) or are receiving a yellow fever vaccination.<br>
									<i class="icon-cancel-2"></i>You are unable to stop taking more than 1.3 grams of aspirin on a daily basis or other non-steroidal anti-inflammatory drugs (NSAIDs).<br>
									<i class="icon-cancel-2"></i>You are unable or unwilling to take folic acid, injections of vitamin B12, or <u>corticosteroids.</u><br>
									<i class="icon-cancel-2"></i>You cannot be pregnant or breastfeeding.<br>
								</ul>								
							</div>                           
						</div>
					</div>	
					<!--<div class="span3 bg-color-pink">
						<img src="images/" class="place-right" style="margin: 10px;height: 0px;width: 0px"/>
						<h2 class="fg-color-white">&nbsp;About Clinical Trials</h2>
					</div>-->
				</div>
				<div class="content">
					<p class="triangle7-isosceles left">Basal-cell carcinoma (BCC), a skin cancer, is the most common cancer.</p>
				</div>
				<div class="content">
					<p class="triangle8-isosceles left">Metastasis, or metastatic disease, is the spread of a cancer from one 
					organ or part to another non-adjacent organ or part</p>
				</div>
				<div class="content">
					<p class="triangle9-isosceles left">Corticosteroids are a class of chemicals that includes steroid hormones 
					naturally produced in the adrenal cortex of vertebrates and analogues of these hormones that are synthesized in 
					laboratories. Corticosteroids are involved in a wide range of physiological processes, including stress response, immune response, etc.</p>
				</div>
			</div>						
			<div class="grid">
				<div class="row">
					<div class="span10 bg-color-red">						
						<h2 class="fg-color-white">&nbsp;<i class="icon-bookmark-3"></i>Design Elements</h2>
						<div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 1080px;">
								<h3>ARMS :</h3>
								<p><b>Experimental</b></p>
								<ul>
									<li>LABEL :  Pemetrexed, Cisplatin</li>
									<li>NUMBER OF ARMS : 2 </li>
								</ul>
	
								<P><b>Placebo Comparator</b></P>
								<ul>
									<li>LABEL : Pemetrexed, Cisplatin, Placebo</li>
									<li>NUMBER OF ARMS : 2</li>
								</ul>
	
								<h3>INTERVENTION :</h3>	
								<ul>
									<li>TYPE : Drug</li>
									<li>NAME : Pemetrexed</li>
									<li>DESCRIPTION :</li> 
									<ul>
										<i class="icon-forward"></i>Mechanism of Action :<br> 
										<i class="icon-forward"></i>Route of Administration : Intravenous(IV)<br>
										<i class="icon-forward"></i>Frequency of Dose : Day 1 of each 21-day cycle for 4 cycles<br>
									</ul>
								</ul>	
								<ul>
									<li>TYPE : Drug</li>
									<li>NAME : Cisplatin</li>
									<li>DESCRIPTION :</li> 
									<ul>
										<i class="icon-forward"></i>Mechanism of Action :<br>
										<i class="icon-forward"></i>Route of Administration : Intravenous(IV)<br>
										<i class="icon-forward"></i>Frequency of Dose : Day 1 of each 21-day cycle for 4 cycles<br>
									</ul>
								</ul>	
								<ul>
									<li>TYPE : Drug</li>
									<li>NAME : Placebo</li>
									<li>DESCRIPTION :</li>
									<ul>
										<i class="icon-forward"></i>Mechanism of Action :<br> 
										<i class="icon-forward"></i>Route of Administration : Intravenous(IV)<br>
										<i class="icon-forward"></i>Frequency of Dose: Day 1 every 21-day cycle until  progressive disease or treatment discontinuation.<br>
									</ul>
								</ul>	
								<ul>
									<li>TYPE : Drug</li>
									<li>NAME: Pemetrexed.</li>
									<li>DESCRIPTION :</li> 
									<ul>
										<i class="icon-forward"></i>Mechanism of Action :<br> 
										<i class="icon-forward"></i>Route of Administration : Intravenous(IV)<br>
										<i class="icon-forward"></i>Frequency of Dose: Day 1 of each 21-day cycle until progressive disease or treatment discontinuation.<br>
									</ul>
								</ul>
								<ul>	
									<li>TYPE : Other.</li>
									<li>NAME: Best supportive care.</li>
									<li>DESCRIPTION : Best Supportive Care is treatment given with the intent to maximize quality of life. 
										Best Supportive Care excludes any treatment in which the goal is to cure or slow the progression of the study disease. 
										Patients will receive Best Supportive Care as judged by their treating physician. 
										Those therapies considered acceptable include, but are not limited to, palliative radiation to extrathoracic structures, 
										antibiotics, analgesics, antiemetics, thoracentesis, pleurodesis, blood transfusions, 
										and/or nutritional support (enteral or parenteral).</li>
								</ul>
								<h3>TIMELINE/SCHEDULE OF EVENTS TYPES :</h3> 
							</div>                           
                        </div>
					</div>	
					<!--<div class="span3 bg-color-pink">
						<img src="images/" class="place-right" style="margin: 10px;height: 0px;width: 0px"/>
						<h2 class="fg-color-white">&nbsp;About Clinical Trials</h2>
					</div> -->
			    </div>
			</div>		
			<div class="grid">
				<div class="row">
					<div class="span6 bg-color-orange">
						<h2 class="fg-color-white">&nbsp;<i class="icon-eye" style="font-size: 40px; color: white;"></i>Outcome Measures : Primary</h2>
						<div class="image-container bg-color-lighten" style="width: 100%">
							<div style="height: 280px;">																	
									<p><b>Description:</b> Investigator-assessed objective PFS was measured from the date of randomization to the first date of objectively determined progressive disease (PD) or death from any cause. For patients not known to have died as of the data cutoff date and who did not have objective PD, PFS was censored at the date of last objective tumor assessment. PD was determined using Response Evaluation Criteria In Solid Tumors (RECIST) criteria. PD = 20% increase in sum of longest diameter of target lesions.</p>
									<p><b>Time Frame:</b> Date of randomization to the date of measured PD or date of death from any cause (up to 19.3 months)</p>																
							</div>
						</div>	
					</div>
				</div>
			</div>
			<div class="grid">
				<div class="row">
					<div class="span8 bg-color-orange">						
						<h2 class="fg-color-white">&nbsp;<i class="icon-eye" style="font-size: 40px; color: white;"></i>Outcome Measures : Secondary</h2>
						<div class="image-container bg-color-blueLight" style="width: 100%">
                            <div style="height: 2000px;">																
									<h4> INDEPENDENTLY-ASSESSED OBJECTIVE PROGRESSION-FREE SURVIVAL (PFS)</h4>
									
									<p><b>Description:</b> To further evaluate the robustness of the PFS analysis, 
										Lilly established an independent review of PFS to assess the potential for 
										investigator bias in the determination of objective PD. PFS was measured from the 
										date of randomization to the first date of objectively determined PD or death. 
										For patients alive as of the data cutoff date and who did not have PD, PFS was censored 
										at the date of the last objective tumor assessment. PD was determined using Response 
										Evaluation Criteria In Solid Tumors (RECIST) criteria. PD = 20% increase in sum of 
										longest diameter of target lesions.</p>
									<p><b>Time Frame:</b> Date of randomization to first date of measured PD or date of 
										death from any cause (up to 19.3 months)</li>
																						
									<h4> OVERALL SURVIVAL (OS)</h4>	
									
									<p><b>Description:</b> OS is the duration from enrollment to death. 
										For patients who are alive, OS is censored at the last contact.</li>
									<p><b>Time Frame:</b> Date of randomization to the date of death from any cause 
										up to 39.5 months.</p>
																								
									<h4> CHANGE FROM BASELINE IN THE EUROQOL INSTRUMENT (EQ-5D) INDEX SCORE</h4>	
									
									<p><b>Description:</b> The EQ-5D is a generic instrument that describes health status in 
										5 attributes (mobility, self-care, pain/discomfort, anxiety/depression, usual activities) using a 
										three level scale (no problem, some problems, and major problems). These combinations of attributes 
										are converted into a weighted health-state Index Score according to the United Kingdom (UK) 
										population-based algorithm. The possible values for the Index Score range from 
										-0.59 (severe problems in all 5 dimensions) to 1.0 (no problem in any dimension).</p>
									<p><b>Time Frame:</b> Baseline randomization through 30-day post-discontinuation visit (up to 19.3 months).</p>
																								
									<h4> CHANGE FROM BASELINE IN EUROQOL INSTRUMENT (EQ-5D) VISUAL ANALOG SCALE (VAS)</h4>	
									
									<p><b>Description:</b> Patients indicate their present health state through completion of the VAS. 
											Possible scores range from 0 (worst imaginable health state) to 100 (best imaginable health state).</p>
									<p><b>Time Frame:</b> Baseline randomization through 30-day post-discontinuation visit (up to 19.3 months).</p>
																							
									<h4> PERCENTAGE OF PARTICIPANTS WITH HOSPITALIZATIONS DUE TO ADVERSE EVENTS OR REQUIRING TRANSFUSION (RESOURCE UTILIZATION).</h4>	
									
									<p><b>Time Frame:</b> Baseline randomization through 30-day post-discontinuation visit (up to 19.3 months).</p>
																								
									<h4> PERCENTAGE OF PARTICIPANTS WITH A NON-SERIOUS ADVERSE EVENT (AE) DURING MAINTENANCE PHASE.</h4>	
									
									<p><b>Description:</b> A summary of non-serious AEs is located in the Reported Adverse Event Module.</p>
									<p><b>Time Frame:</b> Baseline randomization through 30-day post-discontinuation visit (up to 49.7 months).</p>
																									
									<h4> PERCENTAGE OF PARTICIPANTS WITH SERIOUS ADVERSE EVENTS DURING MAINTENANCE PHASE</h4>	
									
									<p><b>Description:</b> A summary of serious adverse events is located in the Reported Adverse Event Module.</p>    
									<p><b>Time Frame:</b> Baseline randomization through 30-day post-discontinuation visit (up to 49.7 months).</p>
																									
									<h4> PERCENTAGE OF PARTICIPANTS WITH OBJECTIVE TUMOR RESPONSE (RESPONSE RATE) DURING MAINTENANCE PHASE OF STUDY UP TO PRIMARY DATA CUT-OFF</h4>
									
									<p><b>Description:</b> Analysis for combined phases was not performed since response was calculated separately for 
									each phase of study. Response using Response Evaluation Criteria In Solid Tumors (RECIST) criteria. 
									Complete Response (CR)=disappearance of all target lesions; Partial Response(PR)is at least a 30% decrease 
									in sum of longest diameter of target lesions; Progressive Disease(PD) is at least a 20% increase in sum of 
									longest diameter of target lesions; Stable Disease(SD)=no change or small changes that do not meet the 
									above criteria for CR, PR, or PD.</p>
									<p><b>Time Frame:</b> Baseline to date of measured progressive disease (up to 19.3 months).</p>
																										
									<h4> PERCENTAGE OF PARTICIPANTS WITH INDEPENDENTLY-ASSESSED OBJECTIVE TUMOR RESPONSE (RESPONSE RATE) DURING MAINTENANCE PHASE UP TO PRIMARY DATA CUT-OFF.</h4>
									
									<p><b>Description:</b> Response using Response Evaluation Criteria In Solid Tumors (RECIST) criteria.
									Complete Response (CR)=disappearance of all target lesions; Partial Response (PR) is at least a 30% decrease 
									in sum of longest diameter of target lesions; Progressive Disease (PD) is at least a 20% increase in sum of 
									longest diameter of target lesions; Stable Disease (SD)=no change or small changes that do not meet the 
									above criteria for CR, PR, or PD. Response Rate = (CR+PR)/Participants in Arm*100. 
									Disease Control Rate=(CR+PR+SD)/Number of Participants in Arm*100.</p>
									<p><b>Time Frame:</b> Date of randomization to date of measured PD (up to 19.3 months).</p>																		
							</div>                   
                        </div>
                    </div>					
				</div>
			</div>				
		</div>	
	</div>				                                          
	<script type="text/javascript" src="js/assets/github.info.js"></script>
    <script type="text/javascript" src="js/assets/google-analytics.js"></script>
    <script type="text/javascript" src="js/google-code-prettify/prettify.js"></script>
    <script src="js/sharrre/jquery.sharrre-1.3.4.min.js"></script>	
</body>
</html>